| scholarly article | Q13442814 |
| case report | Q2782326 |
| P6179 | Dimensions Publication ID | 1049337760 |
| P356 | DOI | 10.1186/S12885-015-1391-X |
| P932 | PMC publication ID | 4440312 |
| P698 | PubMed publication ID | 25962795 |
| P5875 | ResearchGate publication ID | 276210109 |
| P2093 | author name string | Kevin B Kim | |
| Dae Won Kim | |||
| Marta Penas-Prado | |||
| Ashok J Kumar | |||
| Edelyn Barcena | |||
| Michelle L Rohlfs | |||
| Urvi N Mehta | |||
| P2860 | cites work | Leptomeningeal carcinomatosis. Presenting features and prognostic factors. | Q50990635 |
| Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes. | Q54301896 | ||
| Leptomeningeal metastasis | Q81619202 | ||
| Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine | Q84516618 | ||
| Prognostic factors for survival in melanoma patients with brain metastases | Q85226494 | ||
| Improved survival with vemurafenib in melanoma with BRAF V600E mutation | Q24631953 | ||
| Junctions between intimately apposed cell membranes in the vertebrate brain | Q24682725 | ||
| Improved overall survival in melanoma with combined dabrafenib and trametinib | Q27853091 | ||
| Mutations of the BRAF gene in human cancer | Q27860760 | ||
| Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial | Q29614756 | ||
| Leptomeningeal metastases in the MRI era. | Q33853342 | ||
| Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor | Q34484174 | ||
| Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 | ||
| Leptomeningeal metastasis in melanoma: a prospective clinical study of nine patients | Q34645509 | ||
| Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma | Q34664981 | ||
| Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches. | Q35584731 | ||
| Carcinomatous meningitis: Leptomeningeal metastases in solid tumors | Q36851197 | ||
| Prognostic factors and outcomes in patients with leptomeningeal melanomatosis | Q37284337 | ||
| Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report | Q37431085 | ||
| Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis | Q42720641 | ||
| Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial | Q44442912 | ||
| Vemurafenib for leptomeningeal melanomatosis. | Q45941209 | ||
| Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival | Q48170656 | ||
| Quantitative Study of Blood.Brain Barrier Permeability Changes after Experimental Whole-Brain Radiation | Q48552848 | ||
| Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab | Q48553169 | ||
| Influence of radiation on the blood-brain barrier and optimum time of chemotherapy | Q48844058 | ||
| Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors | Q48857140 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 400 | |
| P577 | publication date | 2015-05-13 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report | |
| P478 | volume | 15 |
| Q26769870 | Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy |
| Q90669166 | Contemporary Multidisciplinary Management of Sinonasal Mucosal Melanoma |
| Q49556867 | Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study. |
| Q47133535 | Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy |
| Q48246291 | Leptomeningeal melanoma-A case series in the era of modern systemic therapy |
| Q30251581 | Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy |
| Q38807942 | Melanoma central nervous system metastases: current approaches, challenges, and opportunities |
| Q55327976 | Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments. |
| Q91280474 | Neurologic complications of melanoma |
| Q64118762 | Targeted Therapy After Brain Radiotherapy for BRAF-Mutated Melanoma With Extensive Ependymal Disease With Prolonged Survival: Case Report and Review of the Literature |
Search more.